Shwetal Lalan1, Shuai Jiang2, Derek K Ng2, Fernanda Kupferman3, Bradley A Warady4, Susan Furth5, Mark M Mitsnefes6. 1. Division of Pediatric Nephrology, Department of Pediatrics, Phoenix Children's Hospital, Phoenix, AZ; Department of Pediatrics, Brookdale University Hospital and Medical Center, Brooklyn, NY. Electronic address: slalan@phoenixchildrens.com. 2. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. 3. Department of Pediatrics, Brookdale University Hospital and Medical Center, Brooklyn, NY. 4. Division of Pediatric Nephrology, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, MO. 5. Division of Pediatric Nephrology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA. 6. Division of Pediatric Nephrology and hypertension, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Abstract
OBJECTIVE: To estimate the prevalence of metabolic syndrome (MetS) and examine its association with chronic kidney disease progression in children enrolled in the Chronic Kidney Disease in Children study. STUDY DESIGN: MetS was defined as being overweight or obese and having ≥2 cardiometabolic risk factors (CMRFs). Incidence and prevalence of MetS were assessed using pairs of visits approximately 2 years apart. RESULTS: A total of 799 pairs of person-visits (contributed by 472 children) were included in the final analysis. Of these, 70% had a normal body mass index (BMI), 14% were overweight, and 16% were obese. At the first visit, the prevalence of MetS in the overweight group was 40% and in the obese group was 60%. In adjusted models, annual percent estimated glomerular filtration rate decline in those who had normal BMI and incident or persistent multiple CMRFs or those with persistent MetS was -6.33%, -6.46%, and -6.08% (respectively) compared with children who never had multiple CMRFs (-3.38%, P = .048, .045, and .036, respectively). Children with normal BMI and incident multiple CMRFs and those with persistent MetS had approximately twice the odds of fast estimated glomerular filtration rate decline (>10% per year) compared with those without multiple CMRFs and normal BMI. CONCLUSION: Children with chronic kidney disease have a high prevalence of MetS. These children as well as those with normal BMI but multiple CMRFs experience a faster decline in kidney function.
OBJECTIVE: To estimate the prevalence of metabolic syndrome (MetS) and examine its association with chronic kidney disease progression in children enrolled in the Chronic Kidney Disease in Children study. STUDY DESIGN:MetS was defined as being overweight or obese and having ≥2 cardiometabolic risk factors (CMRFs). Incidence and prevalence of MetS were assessed using pairs of visits approximately 2 years apart. RESULTS: A total of 799 pairs of person-visits (contributed by 472 children) were included in the final analysis. Of these, 70% had a normal body mass index (BMI), 14% were overweight, and 16% were obese. At the first visit, the prevalence of MetS in the overweight group was 40% and in the obese group was 60%. In adjusted models, annual percent estimated glomerular filtration rate decline in those who had normal BMI and incident or persistent multiple CMRFs or those with persistent MetS was -6.33%, -6.46%, and -6.08% (respectively) compared with children who never had multiple CMRFs (-3.38%, P = .048, .045, and .036, respectively). Children with normal BMI and incident multiple CMRFs and those with persistent MetS had approximately twice the odds of fast estimated glomerular filtration rate decline (>10% per year) compared with those without multiple CMRFs and normal BMI. CONCLUSION:Children with chronic kidney disease have a high prevalence of MetS. These children as well as those with normal BMI but multiple CMRFs experience a faster decline in kidney function.
Authors: Hiren P Patel; Jeffrey M Saland; Derek K Ng; Shuai Jiang; Bradley A Warady; Susan L Furth; Joseph T Flynn Journal: J Pediatr Date: 2017-12 Impact factor: 4.406
Authors: Susan L Furth; Alison G Abraham; Judith Jerry-Fluker; George J Schwartz; Mark Benfield; Frederick Kaskel; Craig Wong; Robert H Mak; Marva Moxey-Mims; Bradley A Warady Journal: Clin J Am Soc Nephrol Date: 2011-08-12 Impact factor: 8.237
Authors: Raymond R Townsend; Amanda H Anderson; Jing Chen; Crystal A Gadebegku; Harold I Feldman; Jeffrey C Fink; Alan S Go; Marshall Joffe; Lisa A Nessel; Akinlolu Ojo; Daniel J Rader; Muredach P Reilly; Valerie Teal; Karen Teff; Jackson T Wright; Dawei Xie Journal: Am J Nephrol Date: 2011-04-27 Impact factor: 3.754
Authors: Jing Chen; Paul Muntner; L Lee Hamm; Vivian Fonseca; Vecihi Batuman; Paul K Whelton; Jiang He Journal: J Am Soc Nephrol Date: 2003-02 Impact factor: 10.121
Authors: Peter T Katzmarzyk; Sathanur R Srinivasan; Wei Chen; Robert M Malina; Claude Bouchard; Gerald S Berenson Journal: Pediatrics Date: 2004-08 Impact factor: 7.124
Authors: Susan L Furth; Stephen R Cole; Marva Moxey-Mims; Frederick Kaskel; Robert Mak; George Schwartz; Craig Wong; Alvaro Muñoz; Bradley A Warady Journal: Clin J Am Soc Nephrol Date: 2006-07-19 Impact factor: 8.237
Authors: Amelia S Wallace; Mary R Rooney; Tammy M Brady; Justin B Echouffo-Tcheugui; Robert Christenson; Morgan E Grams; Elizabeth Selvin Journal: Pediatr Diabetes Date: 2021-12-26 Impact factor: 4.866
Authors: Amy J Kogon; Jennifer Roem; Michael F Schneider; Mark M Mitsnefes; Babette S Zemel; Bradley A Warady; Susan L Furth; Nancy M Rodig Journal: Pediatr Nephrol Date: 2022-08-26 Impact factor: 3.651
Authors: Stella Stabouli; Nonnie Polderman; Christina L Nelms; Fabio Paglialonga; Michiel J S Oosterveld; Larry A Greenbaum; Bradley A Warady; Caroline Anderson; Dieter Haffner; An Desloovere; Leila Qizalbash; José Renken-Terhaerdt; Jetta Tuokkola; Johan Vande Walle; Vanessa Shaw; Mark Mitsnefes; Rukshana Shroff Journal: Pediatr Nephrol Date: 2021-08-10 Impact factor: 3.714